Stops Uncontrolled High-Pressure Injections in Peripheral Nerve Blocks

NerveGuard

"Welcome, I would like to help you. Customer Service "Thank you very much for your inquiry. We will get in touch with you as soon as possible."
Please pick your state and I will notify your local representative to contact you."

NerveGuard

Stops Uncontrolled High-Pressure Injections in Peripheral Nerve Blocks

The risk of peripheral nerve injury remains a serious complication, with an incidence of postblock neuropathy reported up to 3 %. The causes include direct needle trauma, chemical injury from local anesthetics or adjuvants, as well as ischemia from vasoconstriction of nutrient vessels within the nerve.2

A central factor influencing the development of such nerve injuries is the injection technique – particularly the control of injection pressure. Studies have shown that an injection pressure of 15 to 20 psi is consistent with safe needle placement. Exceeding this threshold, especially during the initial injection (opening injection pressure, OIP), may indicate intraneural placement – with potentially serious consequences.2

Studies show that injection pressure currently represents the only objective criterion for detecting needle to nerve contact.3 The use of the subjective "hand-feel" technique to avoid high injection pressures is, unfortunately, not reliable as studies with experienced users have shown.1

The NerveGuard is a disposable in-line manometer4 and works as a hard-stop limiter5/pressure-limiter4 rather than a monitor. In-line pressure measurement shows high sensitivity for detection of needle to nerve contact.6 Allowing identification of an inappropriate needle position, and reducing injections performed with excessive pressure.7

NerveGuard Overview

NerveGuard Features & Advantages

STOPS at ≥15 psi
  • NerveGuard stops the fluid flow automatically at 15 psi before intraneural injection can take place.
Clear Pressure Indication
  • No interpretation of the injection pressure information is required and interpretation errors can be avoided.4,5
Flexible Placement
  • The NerveGuard device is designed to be placed between the syringe and tube during peripheral nerve blocks.<sup>4</sup> Alternatively it can be slipped directly into the back of a needle’s hub.
Compact and Compatible
  • Fully functional without the need for additional equipment.
No Distraction
  • The operator handling the syringe can be focused on other aspects of monitoring such as evidence of correct spread on the ultrasound screen or the presence of blood in the injection tube.4

NerveGuard Ordering Info

NerveGuard
Item description NerveGuard | single | sterile | For single shot applications in diameters of 20G/21G/22G
LUER
Item no.
001151-38M
NRFit®
Item no.
001163-38M
Purchase Unit 10

Downloads

Regional Anaesthesia Catalogue

Studies:

1 Choquet O., Capdevila X. Ultrasound-guided nerve blocks: the real position of the needle should be defi ned, Anaesth. Analg. 2012 May; 114(5): 929–930
2 Neil J. M., Brull R., Horn J. L., Liu S. S., McCartney C. J., Perlas A., Salinas F. V., Tsui B. C. The Second American Society of Regional Anesthesia and Pain Medicine Evidence-Based Medicine Assessment of Ultrasound-Guided Regional Anesthe-sia, Reg. Anaesth. Pain Med. 2016 March–April; 41(2): 181–194
3 Robards C., Hadzic A., Somasundaram L., Iwata T., Gadsden J., Xu D., Sala-Blanch X. Intraneural injection with low-current stimulation during popliteal sciatic nerve block, Anesth. 2009 Aug; 109(2): 673– 677
4 Vassiliou T., Müller H. H., Limberg S., De Andres J., Steinfeldt T., Wiesmann T. Risk evaluation for needle-nerve contact related to electrical nerve stimulation in a porcine model, Acta Anaes-thesiol. Scand. 2016 Mar; 60(3): 400–406
6 Hadzic A., Dilberovic F., Shah S., Kulenovic A., Kapur E., Zaciragic A., Cosovic E., Vuckovic I., Divanovic K. A., Mornjakovic Z., Thys D. M., Santos A. C. Combination of intraneural injection and high injection pressure leads to fascicular injury and neurologic deficits in dogs, Reg. Anesth. Pain Med. 2004 September–October; 29(5): 417–423
8 Gadsden J., Choi J. J., Lin E., Robinson A. Opening injection prewssure consistently detects needle-nerve contact during ultrasound-guided interscalene brachial plexus block, Anesthesiology 2014 May; 120(5): 1246–1253
9 Gadsden J., Latmore M., Levine D. M., Robinson A. High Opening Injection Pressure is Associated With Needle-Nerve and Needle-Fascia Contact During Femoral Nerve Block, Reg. Anesth. Pain Med. 2016 Jan–Feb; 41(1): 50–55
10 Steinfeldt T., Graf J., Schneider J., Nimphius W., Weihe E., Borgeat A., Wulf H., Wiesmann T. Histological consequences of needle-nerve contact following nerve stimulation in a pig model, Anesth. Research and Practice 2011; Article ID 591851: 0–9
11 Lundborg G., Myers R., Powell, H. Nerve compression injury and increased endoneurial fluid pressure: a „miniature compartment syndrome“, J. Neurol. Neurosurg. Psychiatry 1983 Dec; 46(12): 1119–1124

NRFit® is a registered trademark of GEDSA and is used with their permission

Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Please contact your country representative for product availability and information. Product images are for reference only.

Other interesting topics